Nevro to Highlight Body of Clinical Evidence Supporting Expanded Use and Potential New Indications of Company's Senza Spinal Cord Stimulation Systems Delivering HF10(TM) Therapy at NANS Annual Meeting

Source :: PR Newswire. January 12, 2018
Publication Year :: 2018
Abstract: Non-Opioid Treatment Option Offers Profound, Paresthesia-Free Pain Relief for Growing Numbers of Patients REDWOOD CITY, Calif. and LAS VEGAS, Jan. 12, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global [...]

Subjects :: Chronic pain -- Drug therapy -- Usage
Pain -- Care and treatment
Evidence-based medicine -- Usage
Business
News, opinion and commentary

Tools